SNYRQ · Synergy CHC Corp. · Financials
$0.01
0.00 (-31.37%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— cleared May 14, 2026
The latest filing states the doubt was alleviated.
“In connection with preparing unaudited condensed consolidated financial statements for the three months ended March 31, 2026, management evaluated whether there were conditions and events, considered in the aggregate, that raised substantial doubt about the Company's ability to continue as a going concern within one year from the date that the unaudited condensed consolidated financial statements are issued. Management concluded that the above factors alleviate doubts about the Company's ability to generate enough cash from operations and other available sources to satisfy its obligations for the next twelve months from the issuance date.”View the 10-Q filed May 14, 2026
Market Cap
$204,128
Shares
14.90M
Volume · Oct 1
256.61K
Avg daily vol (3M)
30.21M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$30.38M
-12.8%
FY2025
Net Income
-$12.34M
-680.8%
FY2025
Gross Margin
66.83%
-1pp
FY2025
Operating Margin
-27.84%
-44.5pp
FY2025
Diluted EPS
-$1.27
-553.6%
FY2025
Operating Cash Flow
-$2.59M
+46.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $27.7M | $30.38M | $34.83M | $42.78M | $29.36M | $33.82M | $35.6M | $34.84M | $13.46M | $9158 | — | |
| — | — | — | — | — | — | — | — | -$1460 | — | $23.2K | |
| — | — | $30M | — | — | — | — | — | — | — | — | |
| $9.59M | $10.08M | $11.19M | $10.7M | $9.14M | $11.04M | $9.82M | $10.21M | $5.31M | $5616 | — | |
| $18.11M | $20.3M | $23.64M | $32.08M | $20.22M | $22.79M | $25.78M | $24.64M | $8.15M | $3542 | — | |
| — | 66.83% | 67.87% | 74.99% | 68.87% | 67.37% | 72.42% | 70.71% | 60.55% | 38.68% | — | |
| $12.72M | $13.14M | $12.99M | $15.19M | $11.47M | $17.7M | $14.04M | $10.33M | $3.69M | — | — | |
| $9.57M | $8.83M | $4.72M | $6.05M | $5.49M | $7.19M | $8.42M | $8.02M | $3.37M | $961.64K | $1583 | |
| $133.33K | $133.33K | $133.33K | $33.33K | — | $1.67M | $1.39M | $1.13M | — | — | — | |
| $133.33K | $133.33K | $133.33K | $33.33K | $1.21M | $1.82M | $1.49M | $1.17M | $608K | — | — | |
| $29.08M | $28.76M | $17.84M | $21.27M | $28.18M | $27.71M | $23.96M | $21.7M | $7.66M | $961.64K | $21.78K | |
| -$10.97M | -$8.46M | $5.8M | $10.81M | -$7.96M | -$4.92M | $1.82M | $2.93M | $486.02K | -$958.09K | — | |
| — | -27.84% | 16.65% | 25.26% | -27.1% | -14.54% | 5.12% | 8.42% | 3.61% | -10461.83% | — | |
| -$10.84M | -$8.33M | $5.93M | $10.84M | -$6.74M | -$3.1M | $3.32M | $4.1M | $1.09M | — | — | |
| $6.84M | $5.92M | $1.55M | $1.69M | — | $1.13M | $1.04M | -$1.57M | -$958.74K | $1998 | $1418 | |
| — | $15.07K | $1523 | $1616 | — | — | — | — | — | — | — | |
| -$4.7M | -$3.76M | -$3.57M | -$4.23M | $1.12M | $1.49M | $1.01M | $2.79M | $7.63M | $1998 | — | |
| -$15.67M | -$12.22M | $2.23M | $6.57M | -$9.08M | -$6.41M | $815.58K | $148.2K | -$7.15M | -$960.09K | — | |
| $115.21K | $117.47K | $102.09K | $234.98K | -$131.54K | $247.69K | $316.01K | $944.36K | $389.95K | $0 | — | |
| -$15.79M | -$12.34M | $2.12M | $6.34M | -$9.21M | -$6.16M | $499.57K | -$796.16K | -$7.54M | -$960.09K | -$23.2K | |
| — | -40.62% | 6.1% | 14.82% | -31.36% | -18.21% | 1.4% | -2.29% | -56.01% | -10483.64% | — | |
| -$15.87M | -$12.45M | $2.18M | $6.21M | -$9.38M | -$5.9M | $405.56K | -$780.14K | -$7.54M | — | — | |
| USD/shares | -$1.60 | -$1.27 | $0.28 | $0.86 | -$0.10 | -$0.07 | $0.01 | — | — | — | — |
| USD/shares | -$1.60 | -$1.27 | $0.28 | $0.86 | -$0.10 | -$0.07 | $0.01 | — | — | — | — |
| shares | — | 9.72M | 7.59M | 7.37M | 89.88M | 89.86M | 89.24M | 81.65M | 68.85M | 97.17M | — |
| shares | — | 9.72M | 7.63M | 7.37M | 89.88M | 89.86M | 89.24M | 81.65M | 68.85M | 97.17M | 5.1M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of notes payable | 2026-03-31 | USD 2,730,981 | 10-Q filed 2026-05-14 |
| Noncurrent debt carrying amount | 2026-03-31 | USD 25,018,055 | 10-Q filed 2026-05-14 |
| Noncurrent notes payable | 2026-03-31 | USD 25,018,055 | 10-Q filed 2026-05-14 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Distribution median 0.74×
EV/EBIT
—
Medical Distribution median 17.37×
P/E (TTM)
—
Medical Distribution median 23.25×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Nutraceuticals | $29,731,664 | $33,392,094 | $42,753,052 |
| Beverages | $631,332 | $1,425,239 | — |
| Consumer Goods | $17,987 | $16,910 | $24,581 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| United States | $27,318,377 | $30,831,188 | $40,621,985 |
| Canada | $2,418,056 | $3,926,370 | — |
| Mexico | $623,660 | $3,638 | — |
| Other | $20,716 | $73,047 | — |
| Foreign Countries | — | — | $2,155,648 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Retail | $22,249,424 | $26,473,946 | $31,775,727 |
| Online | $8,131,385 | $8,360,297 | $11,001,906 |
| License Revenue | $2,900,000 | — | — |